Analysts at Merriman Curhan Ford are out with a positive note on stem cell company Geron (Nasdaq: GERN) today ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE